Neoplasms: all 9,617 studies
Page 65 of 97. Open to participants first (2,509), then studies with results posted, then the rest; newest registration first within each.
- POA Retrospective RepositoryStatus unknownNCT03326479
- Glembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors That Cannot Be Removed by SurgeryWithdrawnNCT03326258Phase 1/2
- POA Prospective RepositoryStatus unknownNCT03324841
- Evaluation of SAR408701 in Japanese Patients With Advanced Malignant Solid TumorsCompletedNCT03324113Phase 1
- Obinutuzumab in Marginal Zone LymphomaActive, not recruitingNCT03322865Phase 2
- EPR Tumor Oximetry With CE India InkTerminatedNCT03321903
- Pharmacokinetic Profile of T-ChOS™ in Subjects With Advanced Solid Tumors (CHITIN)TerminatedNCT03320525Phase 1
- Study Evaluating Safety, Tolerability and Pharmacokinetics (PK) of Tarlatamab in Adults With Small Cell Lung Cancer (SCLC)Active, not recruitingNCT03319940Phase 1
- FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid TumorsCompletedNCT03319459Phase 1
- A Study of a New Investigational Medicinal Product to Treat Patients with Advanced or Metastatic Solid TumorsTerminatedNCT03316638Phase 1/2
- Phase I Study to Assess the Effect of Food on AZD1775 Pharmacokinetics in Patients With Advanced Solid TumoursCompletedNCT03315091Phase 1
- A Study of Patient Preference Between ODM-201 and Enzalutamide in Men With Metastatic Castrate-resistant Prostate CancerCompletedNCT03314324Phase 2
- A Study of Combination Therapy With Venetoclax, Daratumumab and Dexamethasone (With and Without Bortezomib) in Participants With Relapsed or Refractory Multiple MyelomaActive, not recruitingNCT03314181Phase 2
- Modifying Young Adult Skin Cancer Risk and Protective BehaviorsCompletedNCT03313492Not applicable
- Focal Salvage HDR Brachytherapy for Locally Recurrent Prostate Cancer in Patients Treated With Prior RadiotherapyActive, not recruitingNCT03312972Not applicable
- A Study to Evaluate the Safety and Pharmacokinetics ABBV-399 in Japanese Participants With Solid TumorsCompletedNCT03311477Phase 1
- AZD5363 in Patients With Advanced Solid Tumors Harboring AKT MutationsCompletedNCT03310541Phase 1
- Educational Intervention to Increase the Emotional Competence of Patients With Oesogastric and Bronchopulmonary CancersTerminatedNCT03306693Not applicable
- Circulating Tumor DNA As Liquid Biopsy in Patients with Stage IV Solid Tumors, a Feasibility Study At MUSC HCCCompletedNCT03302325
- Study of the Safety and Efficacy of LHC165 Single Agent and in Combination With PDR001 in Patients With Advanced MalignanciesTerminatedNCT03301896Phase 1
- Impact of the Nurse Visit on Observance of the Intake of Oral Carcinological Treatment in the ElderlyTerminatedNCT03300310Not applicable
- Geriatric Oncology Surgical Assessment and Functional rEcovery After SurgeryStatus unknownNCT03299270
- A Study of PLX2853 in Advanced Malignancies.CompletedNCT03297424Phase 1
- A Study of OMP-336B11 in Subjects With Locally Advanced or Metastatic TumorsTerminatedNCT03295942Phase 1
- Comparing Two Techniques of Haemostasis After Cervical ConizationCompletedNCT03293628Phase 2
- IACS-010759 in Advanced CancersCompletedNCT03291938Phase 1
- Study of Universal Screening for Lynch Syndrome in Chinese Patients of Endometrial CancerStatus unknownNCT03291106
- Neoadjuvant Pembrolizumab(Pbr)/Nab-Paclitaxel Followed by Pbr/Epirubicin/Cyclophosphamide in TNBCCompletedNCT03289819Phase 2
- Explore the Clinical Value of 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT in Neuroendocrine NeoplasmsStatus unknownNCT03288597
- A Study to Assess AMG 701 Montherapy, or in Combination With Pomalidomide, With or Without, Dexamethasone in Subjects With Relapsed or Refractory Multiple MyelomaTerminatedNCT03287908Phase 1
- ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016Active, not recruitingNCT03286634Phase 2
- LZM009 to Treat Patients With Advanced Solid TumorsCompletedNCT03286296Phase 1
- Telephone-Based Mindfulness CBT for Patients in Community Settings With Advanced CancerCompletedNCT03285633Not applicable
- Post-Marketing Surveillance Study of OTEZLACompletedNCT03284879
- HM95573 in Combination With Either Cobimetinib or Cetuximab in Patients With Locally Advanced or Metastatic Solid TumorsActive, not recruitingNCT03284502Phase 1
- Comparison Between Mirtazapine and Megestrol for the Control of Anorexia-cachexia in Cancer Patients in Palliative Care.CompletedNCT03283488Phase 2
- Study of Lenalidomide/Dexamethasone With Nivolumab and Ipilimumab in Patients With Newly Diagnosed Multiple MyelomaWithdrawnNCT03283046Phase 1
- NEOadjuvant Chemotherapy Only Compared With Standard Treatment for Locally Advanced Rectal CancerStatus unknownNCT03280407Phase 2
- Tumor Rebiopsy in Children and Adolescents With Recurrent or Progressive Solid MalignanciesCompletedNCT03276702
- Trial of Nab-paclitaxel in Patients With Desmoid Tumors and Multiply Relapsed/Refractory Desmoplastic Small Round Cell Tumors and Ewing SarcomaCompletedNCT03275818Phase 2
- Phase 1 Study of IM156 in Patients With Advanced Solid Tumor and LymphomaCompletedNCT03272256Phase 1
- Apatinib Versus Bevacizumab in Second-line Therapy for Colorectal Cancer(ABST-C)Status unknownNCT03271255Phase 2
- Cognitive-Existential Group Therapy to Reduce Fear of Cancer Recurrence: A RCT StudyCompletedNCT03270995Not applicable
- Comprehensive Segmental Revision SystemActive, not recruitingNCT03270982
- Post Transplant High-Dose Cy as GvHD Prophylaxis in 1 HLA Mismatched Unrelated HSCT for Myeloid MalignanciesCompletedNCT03270748Phase 2
- Shorter Scalp Cooling Time in PaclitaxelCompletedNCT03266185Not applicable
- Registry Protocol- Melphalan Percutaneous Hepatic Perfusion for the Treatment of Unresectable Hepatic MalignancyStatus unknownNCT03266042
- A Study of ADXS-NEO Expressing Personalized Tumor AntigensTerminatedNCT03265080Phase 1
- Study of E7386 in Participants With Selected Advanced NeoplasmsActive, not recruitingNCT03264664Phase 1
- Study to Assess Safety, Tolerability, Pharmacokinetics and Antitumor Activity of AZD4573 in Relapsed/Refractory Haematological MalignanciesCompletedNCT03263637Phase 1
- Type 1 Multiple Endocrine Neoplasia Cohort StudyStatus unknownNCT03262129
- Breast Reconstruction Following Breast Cancer in Very High Risk PatientsWithdrawnNCT03261323Not applicable
- Tool for the Detection of Oncogeriatric Fragility in Patients Aged ≥75 Years Undergoing Oncological Treatment.(D-FOG)CompletedNCT03261128
- U3-1402 in Metastatic or Unresectable Non-Small Cell Lung CancerActive, not recruitingNCT03260491Phase 1
- A Multiple-dose Study of ASP8374, an Immune Checkpoint Inhibitor, as a Single Agent and in Combination With Pembrolizumab in Subjects With Advanced Solid TumorsCompletedNCT03260322Phase 1
- A Dose-escalation, Expansion Study of ARX788, in Advanced Solid Tumors Subjects With HER2 Expression (ACE-Pan Tumor 01)CompletedNCT03255070Phase 1
- Outpatient Percutaneous Radiologic Gastrostomy in Patients With Head and Neck TumorsCompletedNCT03252509Not applicable
- CPR Decision Aid For Patients With Advanced Gynecologic MalignanciesCompletedNCT03251976Not applicable
- Application of Palliative Treatment in Children With Brain Stem Glioma and Recurrent High-grade Tumors in the Central Nervous System With the Nanomaterial NPt-CaCompletedNCT03250520Early Phase 1
- A Study of PD-L1 Antibody KN035 in Japanese Subjects With Locally Advanced or Metastatic Solid TumorsCompletedNCT03248843Phase 1
- TCR-engineered T Cells in Solid Tumors (ACTengine IMA201-101)CompletedNCT03247309Phase 1
- Banding Without Resection in Small Subepithelial TumoursTerminatedNCT03247231
- PIPAC for Peritoneal Metastases of Colorectal CancerCompletedNCT03246321Phase 2
- Megestrol Acetate Plus LNG-IUS in Young Women With Early Endometrial CancerCompletedNCT03241914Phase 2/3
- A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric PatientsCompletedNCT03241550Phase 1
- Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Treat Patients With Advanced CancerTerminatedNCT03240861Phase 1
- Clinical Evaluation of the OncAlert RAPID in Subjects Presenting for Evaluation and/or Initial Biopsy; Impact on Decision-MakingCompletedNCT03239834
- Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) InfectionCompletedNCT03239223Phase 1
- Efficacy and Safety of Precision Therapy in Refractory TumorStatus unknownNCT03239015Phase 2
- Chemotherapy / Radiotherapy in Uterine Cervical NeoplasmsCompletedNCT03238261Not applicable
- A Phase 1 Study to Investigate Axatilimab Alone or in Combination With Durvalumab in Patients With Solid TumorsCompletedNCT03238027Phase 1
- Ribociclib and Gemcitabine Hydrochloride in Treating Patients With Advanced or Metastatic Solid TumorsCompletedNCT03237390Phase 1
- A Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory MalignanciesCompletedNCT03236857Phase 1
- A Safety and Tolerability Study of Pemigatinib in Japanese Subjects With Advanced Malignancies - (FIGHT-102)CompletedNCT03235570Phase 1
- A Study Evaluating the Safety, Pharmacokinetics, and Anti-tumor Activity of ABBV-321 in Subjects With Advanced Solid Tumors Associated With Overexpression of the Epidermal Growth Factor Receptor (EGFR)CompletedNCT03234712Phase 1
- Randomized Clinical Trial Evaluating the Efficacy of Topical Imiquimod in High Grade Cervical Intraepithelial LesionsCompletedNCT03233412Phase 2
- Validation Study of Pediatric Patient-Reported OutcomesCompletedNCT03229837
- Sensory Evaluation of Oral Nutrition Supplements in Patients at Risk for Mucositis Undergoing Cancer TreatmentCompletedNCT03228147Not applicable
- Study of Targeted Therapy Using Transcription Activator-like Effector Nucleases in Cervical Precancerous LesionsStatus unknownNCT03226470Phase 1
- Next Generation Pathogen Sequencing for Prediction of Adverse EventsActive, not recruitingNCT03226158
- Evaluation of Proton Therapy in Pediatric Cancer PatientsActive, not recruitingNCT03223766
- Standardization of Multi-modal Tumor Ablation Therapy SystemStatus unknownNCT03223142Not applicable
- Safety and Immunogenicity of Personalized Genomic Vaccine and Tumor Treating Fields (TTFields) to Treat GlioblastomaActive, not recruitingNCT03223103Phase 1
- A Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of CC-90010 in Subjects With Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin's LymphomasTerminatedNCT03220347Phase 1
- rTMS in Improving Neuropathy in Patients With Stage I-IV Cancer Who Have Received Oxaliplatin ChemotherapyActive, not recruitingNCT03219502Not applicable
- A Study of MGD013 in Patients With Unresectable or Metastatic NeoplasmsCompletedNCT03219268Phase 1
- Physical Cold Atmospheric Plasma for the Treatment of Cervical Intraepithelial NeoplasiaCompletedNCT03218436Not applicable
- ESD Versus TAMIS for Early Rectal NeoplasmsStatus unknownNCT03217773Not applicable
- Tazemetostat in Treating Patients With Metastatic or Unresectable Solid Tumors or B-Cell Lymphomas With Liver DysfunctionWithdrawnNCT03217253Phase 1
- Niraparib Plus Carboplatin in Patients With Homologous Recombination Deficient Advanced Solid Tumor MalignanciesTerminatedNCT03209401Phase 1
- A Trial of HTI-1090 in Subjects With Advanced Solid TumorsCompletedNCT03208959Phase 1
- Understanding the Late Effects of Surviving a Pediatric Brain TumorActive, not recruitingNCT03208387
- Exercise Exposure Data Collection in Patients Undergoing Tumor Molecular ProfilingActive, not recruitingNCT03208374
- Trial Evaluating the Efficacy and Safety of Daratumumab in Subjects With Relapsed/Refractory B-cell or T-cell Precursor Acute Lymphoblastic Leukemia (ALL)WithdrawnNCT03207542Phase 2
- Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent GirlsCompletedNCT03206255
- Safety and Efficacy of GX-188E Administered Via EP Plus GX-I7 or Imiquimod.Status unknownNCT03206138Not applicable
- COZMOS:Phase I/Ib Trial of Combined 5'Azacitidine and Carboplatin for Recurrent/Refractory Pediatric Brain/Solid TumorsCompletedNCT03206021Phase 1
- Study of Brentuximab Vedotin Plus TAK228 for Relapsed/Refractory Classical Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma and Other CD30+Peripheral T-Cell LymphomasWithdrawnNCT03205891Phase 1
- AZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including LymphomasCompletedNCT03205176Phase 1
- Oral Supplementation to Enhance Recovery Pilot StudyCompletedNCT03204266Early Phase 1